Terminology Service < Semantic Lookup Platform

All terms in NCIT

Label	Id	Description
Q-LES-Q - Look Forward to Leisure Activities	NCIT_C130674	[Quality Of Life Enjoyment And Satisfaction Questionnaire (Q-LES-Q) How often did you look forward to the leisure activities before spending time at them?]
Gagging	NCIT_C34630	[The sudden, coordinated, involuntary contraction of pharyngeal muscles in an attempt to prevent any matter from passing into the posterior pharynx; it is stimulated by touching the posterior palate, tongue, or pharynx, or by psychic stimuli.]
Digestive System Signs and Symptoms	NCIT_C3368	[Signs and symptoms associated with disturbances within the digestive system, which includes the stomach, intestines and all associated organs that aid in digestion.]
Q-LES-Q - Concentrate on Leisure Activities	NCIT_C130675	[Quality Of Life Enjoyment And Satisfaction Questionnaire (Q-LES-Q) How often did you concentrate on the leisure activities and pay attention to them?]
Gallbladder Disorder	NCIT_C34631	[A non-neoplastic or neoplastic disorder that affects the gallbladder. Representative examples of non-neoplastic disorders include acute and chronic cholecystitis, often associated with the presence of gallstones. Representative examples of neoplastic disorders include adenoma, carcinoma, lymphoma, and sarcoma.]
Biliary System Disorder	NCIT_C2899	[A non-neoplastic or neoplastic disorder that affects the intrahepatic or extrahepatic bile ducts or the gallbladder. Representative examples of non-neoplastic disorders include cholangitis and cholecystitis. Representative examples of neoplastic disorders include extrahepatic bile duct adenoma, intrahepatic and extrahepatic cholangiocarcinoma, and gallbladder carcinoma.]
Q-LES-Q - Solve or Deal Without Undue Stress	NCIT_C130676	[Quality Of Life Enjoyment And Satisfaction Questionnaire (Q-LES-Q) If a problem arose in your leisure activities, how often did you solve it or deal with it without undue stress?]
Q-LES-Q - Leisure Activity Sustain Interest	NCIT_C130677	[Quality Of Life Enjoyment And Satisfaction Questionnaire (Q-LES-Q) How often did the leisure activities sustain your interest?]
Q-LES-Q - Enjoyed Being With Friends	NCIT_C130678	[Quality Of Life Enjoyment And Satisfaction Questionnaire (Q-LES-Q) During the past week how often have you: enjoyed talking with or being with friends or relatives?]
Q-LES-Q - Getting Together With Friends	NCIT_C130679	[Quality Of Life Enjoyment And Satisfaction Questionnaire (Q-LES-Q) During the past week how often have you: looked forward to getting together with friends or relatives?]
International Staging System Stage	NCIT_C139007	[A plasma cell myeloma stage defined according to the international staging system.]
Plasma Cell Myeloma by ISS Stage	NCIT_C139009	[A header term that refers to the staging of plasma cell myeloma according to the International Staging System.]
Micellar Nanoparticle-encapsulated Epirubicin	NCIT_C139003	[A nanoparticle-based prodrug formulation consisting of polymeric micelles encapsulating the anthracycline epirubicin, with potential antineoplastic activity. Epirubicin is covalently bound to polyethylene glycol (PEG) polyaspartate block copolymers through an acid-labile hydrazone bond and, upon suspension in an aqueous solution, a micellar structure with an outer hydrophilic PEG shell surrounding the hydrophobic epirubicin is formed. Upon administration of the micellar nanoparticle-encapsulated epirubicin, the nanoparticles are stable in the bloodstream and specifically accumulate in the tumor tissue. Due to the acidic conditions in the tumor and the pH-responsive nature of the micelles, epirubicin is released in the tumor milieu; it then intercalates into DNA and inhibits topoisomerase II, which inhibits DNA replication and interferes with synthesis of both RNA and protein. Compared to the administration of epirubicin alone, this formulation increases the water-solubility of epirubicin and increases its therapeutic effect while decreasing its cardiotoxicity.]
Q-LES-Q - Felt Good Doing Course Work	NCIT_C130670	[Quality Of Life Enjoyment And Satisfaction Questionnaire (Q-LES-Q) During the past week how much of the time have you: felt good while doing your course/class work?]
Pan-FGFR Inhibitor LY2874455	NCIT_C139004	[An orally bioavailable pan-inhibitor of fibroblast growth factor receptor (FGFR) family proteins, with potential antineoplastic activity. Upon oral administration, FGFR inhibitor LY2874455 binds to and inhibits FGFR subtypes 1 (FGFR1), 2 (FGFR2), 3 (FGFR3) and 4 (FGFR4), which results in the inhibition of FGFR-mediated signal transduction pathways. This inhibits both tumor angiogenesis and proliferation of FGFR-overexpressing tumor cells. FGFR, a family of receptor tyrosine kinases upregulated in many tumor cell types, plays a key role in cellular proliferation, cell survival and angiogenesis.]
Q-LES-Q - Communicated With Ease at Course	NCIT_C130671	[Quality Of Life Enjoyment And Satisfaction Questionnaire (Q-LES-Q) During the past week how much of the time have you: communicated and interacted with ease with others at your course/class?]
Q-LES-Q - Use Time for a Leisure Activity	NCIT_C130672	[Quality Of Life Enjoyment And Satisfaction Questionnaire (Q-LES-Q) When you had time, how often did you use that time for a leisure time activity?]
Durie/Salmon Stage	NCIT_C139006	[A plasma cell myeloma stage defined according to the Durie/Salmon staging system.]
Glioma Lysate Vaccine GBM6-AD	NCIT_C139000	[An allogeneic cell lysate-based vaccine derived from the glioma stem cell line GBM6-AD, which was isolated from the brain tumor of a patient diagnosed with glioblastoma multiforme (GBM), with potential immunostimulatory and antineoplastic activities. Upon subcutaneous administration, the glioma lysate vaccine GBM6-AD exposes the immune system to an undefined amount of glioma-associated antigens (GAAs), and stimulates the immune system to mount a specific anti-tumoral, cytotoxic T-lymphocyte (CTL)-mediated response against the GAA-expressing cells, resulting in glioma cell lysis.]
Refractory Soft Tissue Sarcoma	NCIT_C139001	[A soft tissue sarcoma that does not respond to treatment.]